Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy

<table>A flow diagram describing the cohort with virological breakthrough (&gt;1000 copies/mL) as a subset of ART-naïve adults commencing treatment at the HCTC and subsequent outcomes.</table>

AIDS Research and Treatment

fig1

Figure 1

Figure 1: Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy 